Evidence map›Paper›PMID 42043881›Full record

ArticleJournal of the American Society of Nephrology : JASN2026

Sphingolipids and Mortality in Hemodialysis: Innocent Bystanders or Causal Culprits?

Keith L Saum, Subramaniam Pennathur

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Keith L SaumDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-3851-1039
Subramaniam PennathurDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-3628-6883

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Joyce Lee · 2010 to 2026
$20.3M
University of Michigan O'Brien Kidney Translational Resource Center (MKTC)U54DK137314 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Subramaniam Pennathur · 2023 to 2026
$4.7M
Training CoreTL1DK136046 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Laura H Mariani · 2022 to 2026
$2.5M
University of Michigan Kidney, Urology and Hematology Research Training NetworkU2CDK129445 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BENJAMIN L MARGOLIS · 2022 to 2026
$2.0M
American Heart Association 26CDA1601970Juvenile Diabetes Research Foundation 5-COE-2019-861-S-BNIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK089503NIDDK NIH HHS P30DK89503NIDDK NIH HHS TL1 DK136046NIDDK NIH HHS TL1DK136046NIDDK NIH HHS U2C DK129445NIDDK NIH HHS U2CDK129445NIDDK NIH HHS U54 DK137314NIDDK NIH HHS U54DK137314
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cardiovascular diseasechronic hemodialysislipids

Identifiers

PMID42043881
PMCPMC13220913

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.